CD8 Activators
The chemical class of T-CD8 activators comprises a diverse range of compounds that intricately modulate the activation of CD8-positive T cells, crucial effectors of the adaptive immune system. These activators exert their influence through direct or indirect mechanisms, orchestrating a symphony of signaling events that culminate in enhanced CD8 activation and effector functions. At the forefront of this chemical ensemble is Phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC), directly stimulating CD8 by initiating PKC-dependent signaling. Mimicking the physiological activator diacylglycerol, PMA triggers downstream events that enhance CD8 activation, providing valuable insights into the role of PKC in T cell responsiveness. Ionomycin, a calcium ionophore, takes center stage by directly activating CD8 through the elevation of intracellular calcium levels. By facilitating calcium influx, ionomycin orchestrates calcium-dependent signaling pathways, unraveling critical molecular events associated with CD8 activation and function.
Diacylglycerol, a second messenger, assumes a pivotal role by directly activating CD8 through the promotion of PKC-dependent signaling. As a physiological activator of PKC, diacylglycerol enhances CD8 activation, providing a molecular basis for understanding the role of diacylglycerol signaling in T cell activation. Ingenol-3-angelate, another PKC activator, adds a nuanced layer to the symphony by directly stimulating CD8 through PKC-dependent pathways. NSC 23766, a Rac1 inhibitor, indirectly activates CD8 by modulating Rac1-dependent signaling. By inhibiting Rac1, NSC 23766 disrupts downstream pathways, contributing to increased CD8 activation and T cell responsiveness. Nifedipine, a calcium channel blocker, indirectly activates CD8 by modulating calcium-dependent signaling, offering a pharmacological approach to investigate the regulatory role of calcium signaling in CD8 function. In conclusion, the T-CD8 activators constitute a diverse repertoire of compounds that intricately modulate the activation of CD8-positive T cells.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a PKC activator, directly activates CD8 by stimulating PKC-dependent signaling. Acting as a mimic of diacylglycerol, PMA activates PKC, leading to downstream signaling events that enhance CD8 activation and T cell responsiveness. This compound serves as a potent inducer of CD8 activation, providing insights into the role of PKC-mediated signaling in T cell activation and immune responses. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, directly activates CD8 by elevating intracellular calcium levels. By facilitating calcium influx, ionomycin triggers calcium-dependent signaling pathways that enhance CD8 activation and T cell function. This compound serves as a pharmacological tool to dissect the impact of calcium signaling on CD8 activation, unraveling key molecular events associated with T cell responsiveness and effector functions. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1, a PKC modulator, directly activates CD8 by influencing PKC-dependent signaling. Acting as a potent PKC activator, bryostatin 1 enhances CD8 activation and T cell responsiveness. This compound represents a unique pharmacological tool to dissect the role of PKC modulation in CD8 function, shedding light on the intricate regulatory mechanisms governing T cell activation and immune responses. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a SERCA inhibitor, directly activates CD8 by inducing calcium release from the endoplasmic reticulum. By inhibiting SERCA pumps, thapsigargin disrupts calcium homeostasis, leading to increased intracellular calcium levels and subsequent CD8 activation. This compound serves as a valuable tool to explore the impact of calcium signaling on CD8 function, unraveling key molecular events associated with T cell responsiveness and effector functions. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
Diacylglycerol, a second messenger, directly activates CD8 by promoting PKC-dependent signaling. As a physiological activator of PKC, diacylglycerol enhances CD8 activation and T cell responsiveness. This compound serves as a key mediator of PKC-dependent pathways in CD8 function, providing a molecular basis for understanding the role of diacylglycerol signaling in T cell activation and immune regulation. | ||||||
Ingenol 3-angelate | 75567-37-2 | sc-364214 sc-364214A | 1 mg 5 mg | $189.00 $734.00 | 3 | |
Ingenol-3-angelate, a PKC activator, directly activates CD8 by stimulating PKC-dependent signaling. Acting as an analog of diacylglycerol, ingenol-3-angelate enhances CD8 activation and T cell responsiveness through the activation of PKC. This compound represents a pharmacological tool to dissect the impact of PKC modulation on CD8 function, unraveling key molecular events associated with T cell activation and immune responses. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506, a calcineurin inhibitor, indirectly activates CD8 by inhibiting calcineurin-dependent signaling. By preventing calcineurin activation, FK506 disrupts downstream signaling events, leading to increased CD8 activation and T cell responsiveness. This compound serves as a pharmacological tool to explore the regulatory role of calcineurin in CD8 function, offering insights into the molecular mechanisms governing T cell activation and immune responses. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, directly activates CD8 by promoting calcium influx. By facilitating calcium entry, A23187 triggers calcium-dependent signaling pathways that enhance CD8 activation and T cell function. This compound serves as a pharmacological tool to dissect the impact of calcium signaling on CD8 function, unraveling key molecular events associated with T cell responsiveness and effector functions. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, indirectly activates CD8 by modulating calcium-dependent signaling. By inhibiting calcium entry through voltage-gated calcium channels, nifedipine disrupts downstream pathways, leading to increased CD8 activation and T cell responsiveness. | ||||||